McLaughlin Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.39M Buy
2,053
+1
+0% +$594 1.09% 26
2026
Q2
$1.03M Buy
2,052
+11
+0.5% +$5.28K 0.71% 38
2026
Q1
$1M Sell
2,041
-34
-2% -$18.5K 0.96% 36
2025
Q4
$1.2M Buy
+2,075
New +$1.17M 1.08% 27

Other funds holding TMO

McLaughlin Asset Management's TMO Position: Q3 2026 in Review

McLaughlin Asset Management increased its Thermo Fisher Scientific (TMO) stake by 0.05% in Q3 2026, buying an estimated $594 and bringing the position to 2,053 shares worth $1.39M. The position accounts for 1.09% of the portfolio, ranked #26.

McLaughlin Asset Management first reported a position in TMO in Q4 2025 and has held it in 4 quarters since. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • McLaughlin Asset Management held 2,053 shares of Thermo Fisher Scientific worth $1.39M as of Q3 2026.
  • McLaughlin Asset Management bought 1 Thermo Fisher Scientific share in Q3 2026, an estimated $594.
  • Thermo Fisher Scientific made up 1.09% of McLaughlin Asset Management's portfolio in Q3 2026, its #26 holding.
  • McLaughlin Asset Management first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 4 quarters since.
  • 1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on McLaughlin Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.